DRTS

7.39

1.86% -0.14

Dopo l'orario di chiusura: 7.38 -0.010 -0.14%

Alpha Tau Medical Ltd (DRTS)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$7.53

Aprire:

$7.76

Volume 24 ore:

755.86K

Relative Volume:

2.33

Capitalizzazione di mercato:

$650.39M

Reddito:

Utile/perdita netta:

$-42.63M

Rapporto P/E:

-13.99

EPS:

-0.5281

Flusso di cassa netto:

$-39.43M

1 W Prestazione:

+1.23%

1M Prestazione:

+6.79%

6M Prestazione:

+86.62%

1 anno Prestazione:

+184.23%

Intervallo 1D:

$7.1701

$7.8584

Intervallo di 1 settimana:

$7.15

$9.071

Portata 52W:

$2.57

$9.071

Alpha Tau Medical Ltd Stock (DRTS) Company Profile

Nome

Alpha Tau Medical Ltd

Settore

Healthcare (1106)

Industria

Biotechnology (615)

Telefono

Indirizzo

Dipendente

121

Cinguettio

Prossima data di guadagno

2026-05-18

Ultimi documenti SEC

DRTS's Discussions on Twitter

Compare DRTS vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DRTS Alpha Tau Medical Ltd	7.39	662.71M	0	-42.63M	-39.43M	-0.5281
VRTX Vertex Pharmaceuticals Inc	424.36	109.34B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	74.35B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	50.44B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	39.78B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.02B	5.36B	287.73M	924.18M	2.5229

Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-04	Downgrade	Piper Sandler	Overweight → Neutral
2023-12-15	Iniziato	Citigroup	Buy
2023-04-24	Iniziato	H.C. Wainwright	Buy
2022-04-14	Iniziato	Cantor Fitzgerald	Overweight
2022-04-08	Iniziato	Piper Sandler	Overweight
2022-04-04	Iniziato	Citigroup	Buy

Mostra tutto

Alpha Tau Medical Ltd Borsa (DRTS) Ultime notizie

May 05, 2026

Alpha Tau to Present Alpha DaRT–Pembrolizumab Head and Neck Cancer Data at AHNS 2026 - TipRanks

May 05, 2026

Alpha Tau abstract on cancer therapy accepted for presentation By Investing.com - Investing.com Canada

May 05, 2026

Elderly head and neck cancer study gets AHNS podium slot - Stock Titan

May 05, 2026

Alpha Tau (DRTS) wins AHNS podium slot for Alpha DaRT and pembrolizumab head and neck cancer study - Stock Titan

May 05, 2026

May 04, 2026

Alpha Tau pancreatic data: 19 of 19 controlled, 8 device events - Stock Titan

May 04, 2026

Alpha Tau reports disease control in pancreatic cancer trial By Investing.com - Investing.com Australia

May 04, 2026

Alpha Tau reports disease control in pancreatic cancer trial - Investing.com

May 04, 2026

Alpha Tau Reports 100% Local Disease Control in Alpha DaRT Pancreatic Cancer Trials Presented at DDW 2026 - TipRanks

May 04, 2026

Alpha Tau Announces 100% Local Disease Control Rate and - GlobeNewswire

May 04, 2026

[EFFECT] Alpha Tau Medical Ltd. SEC Filing - Stock Titan

May 04, 2026

May 02, 2026

Alpha Tau Medical (NASDAQ:DRTS) Reaches New 1-Year HighTime to Buy? - MarketBeat

May 02, 2026

May 01, 2026

Alpha Tau Medical (NASDAQ:DRTS) Sees Strong Trading VolumeHere's What Happened - MarketBeat

May 01, 2026

Apr 30, 2026

Alpha Tau Medical (NASDAQ:DRTS) Trading Up 13.6%Here's What Happened - MarketBeat

Apr 30, 2026

Apr 28, 2026

Alpha Tau Medical (NASDAQ: DRTS) files $300M shelf; $100M ATM pact - Stock Titan

Apr 28, 2026

Apr 27, 2026

Alpha Tau to Present Pooled Pancreatic Cancer Alpha DaRT Data at 2026 ASCO Meeting - TipRanks

Apr 27, 2026

Alpha Tau abstract accepted at ASCO annual meeting in May - Investing.com

Apr 27, 2026

Alpha Tau abstract accepted at ASCO annual meeting in May By Investing.com - Investing.com Canada

Apr 27, 2026

Alpha Tau Announces Presentation of Pancreatic Cancer Data - GlobeNewswire

Apr 27, 2026

Alpha Tau (Nasdaq: DRTS) ASCO abstract pools 58 pancreatic cancer patients - Stock Titan

Apr 27, 2026

H.C. Wainwright reiterates Alpha Tau Medical stock rating on FDA approval - Investing.com

Apr 27, 2026

H.C. Wainwright reiterates Alpha Tau Medical stock rating on FDA approval By Investing.com - Investing.com South Africa

Apr 27, 2026

Apr 25, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Apr 25, 2026

Apr 23, 2026

Alpha Tau Wins FDA Clearance To Expand Alpha DaRT Pancreatic Cancer Trial - RTTNews

Apr 23, 2026

Alpha Tau Treats First European Pancreatic Cancer Patient With Alpha DaRT in ACAPELLA Trial - TipRanks

Apr 23, 2026

Alpha Tau (NASDAQ: DRTS) advances Alpha DaRT pancreatic cancer clinical trials - Stock Titan

Apr 23, 2026

Alpha Tau expands pancreatic cancer trial to 40, adds second chemo - Stock Titan

Apr 23, 2026

Alpha Tau Successfully Treats First Pancreatic Cancer - GlobeNewswire

Apr 23, 2026

Alpha Tau Medical Ltd. (NASDAQ:DRTS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Apr 23, 2026

Alpha Tau Medical (DRTS) 43rd Annual J.P. Morgan Healthcare Conference 2025 Summary - Quartr

Apr 23, 2026

Apr 22, 2026

Alpha Tau Medical (DRTS) Investor presentation Summary - Quartr

Apr 22, 2026

Alpha Tau Medical (DRTS) 2nd Annual Lytham Partners Healthcare Investor Summit summary - Quartr

Apr 22, 2026

Is Alpha Tau (DRTS) stock trading at a discount | Q4 2025: Profit Exceeds ViewsPopular Market Picks - Cổng thông tin điện tử Tỉnh Sơn La

Apr 22, 2026

DRTS (Alpha Tau Medical Ltd. Ordinary Shares) posts narrower Q4 2025 loss than estimates, shares rise 0.75 percent today.GDR - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 18, 2026

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Immunome (IMNM) and Eli Lilly & Co (LLY) - The Globe and Mail

Apr 18, 2026

Apr 17, 2026

Michael Avruch Net Worth (2026) - GuruFocus

Apr 17, 2026

Uzi Sofer Net Worth (2026) - GuruFocus

Apr 17, 2026

Raphi Levy Net Worth (2026) - GuruFocus

Apr 17, 2026

Apr 16, 2026